큐로셀

372320KOSDAQSector: Pharma & Biotech

₩22,100▼ 1.56%Market cap ₩336.5BAs of Jul 21, 2026 close · updated once daily

Grade F7.6 ptsTop 100% of 2,523 stocks

Financial strength

1.7

Price attractiveness

14.3

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

ⓘ Growth momentum not rated — will be included automatically as data accumulates

Financial strength

1.7

How much debt does it carry relative to equity?

Debt-to-equity ratio

2083.4%

✗ Below median · Top 98.6% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

33.3%

✗ Below median · Top 97.8% in sector

Sector median 191.3%

How much did it earn on its own capital?

ROE (return on equity)

-921.5%

✗ Below median · Top 98.6% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

Did core profits grow in a year?

Operating income change (YoY)

0.9%

✗ Below median · Top 54.2% in sector

Sector median 3.6%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

14.3

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 75.4% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

67.11x

✗ Below median · Top 96.1% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15